文献速递癫痫认知障碍与痴呆

弥漫性胶质瘤组织2-羟基戊二酸与术前癫痫发作的关系

Tissue 2-Hydroxyglutarate and Preoperative Seizures in Patients With Diffuse Gliomas.
PubMed 文献 · Neurology · 2021-10-05

该研究纳入104例弥漫性胶质瘤手术患者,检测组织2-羟基戊二酸(2HG)浓度并分析其与术前癫痫的关系。结果显示IDH突变型肿瘤组织2HG浓度显著高于野生型,且高2HG浓度与术前癫痫独立相关(OR 5.86)。

要点

  • IDH突变型胶质瘤组织2HG浓度中位4860 ng/mg,远高于野生型的75 ng/mg。
  • 术前癫痫在IDH突变型中占64.3%,野生型中占21.0%。
  • 组织2HG浓度预测术前癫痫的最佳截断值为1190 ng/mg。

核心结论

  • 高组织2HG浓度与弥漫性胶质瘤患者术前癫痫发作独立相关(OR 5.86,95%CI 1.02-48.5,p=0.048)。

研究设计与样本

  • 纳入2008年8月至2016年5月手术的104例弥漫性胶质瘤患者,检测组织2HG浓度并分析其与术前癫痫的关系。
  • 对12例手术切除样本应用MALDI-MSI评估2HG分布。

主要发现

  • IDH突变型肿瘤组织2HG浓度中位4860 ng/mg,显著高于野生型的75 ng/mg(p<0.0001)。
  • MALDI-MSI仅在IDH突变型中检测到2HG信号,野生型未检测到。
  • 术前癫痫在IDH突变型中占64.3%,野生型中占21.0%(p<0.0001)。

关键数值与推荐

  • 组织2HG浓度预测术前癫痫的最佳截断值为1190 ng/mg(ROC曲线计算)。
  • IDH突变型中,2HG高于截断值者术前癫痫占71.4%,低于截断值者占28.6%(p=0.031)。
  • 多因素分析仅组织2HG浓度升高与术前癫痫相关(OR 5.86,95%CI 1.02-48.5,p=0.048)。

临床怎么用

  • 对IDH突变型弥漫性胶质瘤患者,可关注组织2HG浓度以评估术前癫痫风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Mutant isocitrate dehydrogenase (IDH) 1/2 gene products gain a new ability to produce D-2-hydroxyglutarate (D2HG). IDH1/2 mutations are thought to be associated with seizures owing to the structural similarity between D2HG and glutamate. However, the effects of D2HG on seizures in clinical settings are not fully understood. We sought to investigate the relationship between tissue 2-hydroxyglutarate (2HG) concentration and preoperative seizures using clinical samples. METHODS: We included 104 consecutive patients with diffuse glioma who underwent surgery from August 2008 to May 2016 and whose clinical presentation and IDH1/2 status were identified. The presence of preoperative seizures, tumor location, histopathologic diagnosis, IDH1/2 status, and 1p/19q codeletion were assessed from the patient charts. Tissue 2HG concentration was measured using liquid chromatography-tandem mass spectrometry. To evaluate 2HG distribution without artefactual tissue disruption, we applied matrix-assisted laser desorption/ionization high-resolution mass spectrometry imaging (MALDI-MSI) in 12 patients' surgically resected samples. We assessed the correlation of preoperative seizures with tissue 2HG concentration, IDH1/2 status, WHO grade, and 1p/19q codeletion. RESULTS: Tissue 2HG concentration was higher in IDH1/2 mutant tumors (IDH-Mut, n = 42) than in IDH1/2 wild-type tumors (IDH-WT, n = 62) (median 4,860 ng/mg vs 75 ng/mg) (p < 0.0001). MALDI-MSI could detect 2HG signals in IDH-Mut, but not in IDH-WT. Preoperative seizures were observed in 64.3% of patients with IDH-Mut and 21.0% patients with IDH-WT (p < 0.0001). The optimal cutoff value of tissue 2HG concentration for predicting preoperative seizures was 1,190 ng/mg, as calculated by the receiver operating characteristic curve. Increased preoperative seizure risk was only observed in tumors with 2HG concentration above the cutoff value among IDH-Mut (IDH-Mut with above the cutoff value: 71.4% vs IDH-Mut with below the cutoff value: 28.6%; p = 0.031). Multivariate analysis, including IDH1/2 mutation status, tissue 2HG concentration, WHO grade, and 1p/19q codeletion, revealed that only increased tissue 2HG concentration was associated with preoperative seizures (odds ratio 5.86, 95% confidence interval 1.02-48.5; p = 0.048). DISCUSSION: We showed that high tissue 2HG concentration was associated with preoperative seizures, suggesting that excess 2HG increases risk of preoperative seizures in IDH1/2 mutant tumors.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ohno M, Hayashi Y, Aikawa H, et al. Tissue 2-Hydroxyglutarate and Preoperative Seizures in Patients With Diffuse Gliomas. Neurology. 2021. PMID: 34610989. doi:10.1212/WNL.0000000000012893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。